2208 GMT - Barrenjoey thinks it will take the market some time to digest James Hardie's US$8.7 billion acquisition of Azek, and downgrades the stock to neutral from overweight as a result. "Azek appears to be a high-quality company but we see the following challenges with the deal," says analyst Brook Campbell-Crawford in a note. Those challenges include a 7% drag on James Hardie's EPS in FY 2026 and FY 2027, and an offer premium that exceeds the likely savings that can be made. It also raises James Hardie's pro-forma leverage to 2.5x in FY 2026, from 0.7x in FY 2024, going into a deteriorating new housing market in the U.S., Barrenjoey says.(david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
March 24, 2025 18:08 ET (22:08 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。